Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
11 hedge funds and large institutions have $1.63M invested in Timber Pharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
511% more capital invested
Capital invested by funds: $267K → $1.63M (+$1.37M)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
22% more funds holding
Funds holding: 9 → 11 (+2)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$585K |
| 2 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$226K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$105K |
| 4 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$61.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$39.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.63K |
| 3 |
CPG
Cornerstone Planning Group
Fairfield,
New Jersey
|
-$386 |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Tudor Investment Corp
Stamford,
Connecticut
| $747K | +$585K | +251,037 | New |
|
|
PCM
2
PenderFund Capital Management
Vancouver,
British Columbia, Canada
| $391K | +$226K | +96,790 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $134K | +$105K | +45,105 | New |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $115K | – | – | – |
|
|
YCM
5
Yakira Capital Management
Westport,
Connecticut
| $78.4K | +$61.4K | +26,366 | New |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $66.3K | +$5.81K | +2,493 | +13% |
|
|
7
Citadel Advisors
Miami,
Florida
| $48.4K | -$39.4K | -16,925 | -51% |
|
8
State Street
Boston,
Massachusetts
| $43K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $5.35K | -$2.63K | -1,127 | -39% |
|
10
UBS Group
Zurich,
Switzerland
| $4.94K | +$2K | +859 | +107% |
|
11
Wells Fargo
San Francisco,
California
| $65 | – | – | – |
|
|
CPG
12
Cornerstone Planning Group
Fairfield,
New Jersey
| – | -$386 | -159 | Closed |
|
|
SPIA
13
Steward Partners Investment Advisory
New York
| – | -$2 | -1 | Closed |
|
TMBR Hedge Fund Activity: Q3 2023 in Review
11 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q3 2023, worth a combined $1.63M — up 511% from $267K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TMBR positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Tudor Investment Corp, opening a new position worth an estimated $585K. The largest seller was Citadel Advisors, cutting an estimated $39.4K.
- 11 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q3 2023, up from 9 in Q2 2023.
- Funds reported $1.63M of Timber Pharmaceuticals, Inc. stock for Q3 2023, up 511% quarter-over-quarter.
- 4 funds opened new Timber Pharmaceuticals, Inc. positions in Q3 2023 and 2 closed out, a net change of +2 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q3 2023 was Tudor Investment Corp, an estimated $585K added.
- The largest Timber Pharmaceuticals, Inc. seller in Q3 2023 was Citadel Advisors, an estimated $39.4K sold.
Based on aggregated 13F filings for Q3 2023.